136 related articles for article (PubMed ID: 37251402)
1. Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancer.
Yang J; Hu X; Wang Y; Liu W; Zhang M; Zhang A; Ni B
Front Immunol; 2023; 14():1180449. PubMed ID: 37251402
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway.
Wang Z; Guo Z; Wang X; Liao H; Chai Y; Wang Z; Wang Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552722
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
5. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
6. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
Li H; Wu C; Chang W; Zhong L; Gao W; Zeng M; Wen Z; Mai S; Chen Y
Front Biosci (Landmark Ed); 2023 Oct; 28(10):243. PubMed ID: 37919070
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Zhou M; Chen Y; Gu X; Wang C
Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
[No Abstract] [Full Text] [Related]
10. A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer.
Han Y; Liu SM; Jin R; Meng W; Wu YL; Li H
Front Immunol; 2023; 14():1178193. PubMed ID: 37492578
[TBL] [Abstract][Full Text] [Related]
11. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
Ma Q; Geng K; Xiao P; Zeng L
Biomed Res Int; 2021; 2021():5963868. PubMed ID: 34518802
[TBL] [Abstract][Full Text] [Related]
12. Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming.
Cao S; Xiao S; Zhang J; Li S
Front Endocrinol (Lausanne); 2023; 14():1147366. PubMed ID: 37091844
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.
Hu Y; Zeng N; Ge Y; Wang D; Qin X; Zhang W; Jiang F; Liu Y
Front Endocrinol (Lausanne); 2022; 13():847760. PubMed ID: 35432196
[TBL] [Abstract][Full Text] [Related]
14. Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancer.
Li XT; Zhang JT; Yan HH; Su J; Cheng ML; Sun QH; Zhong WZ; Wu YL; Zhang DX; Hou DJ
Cancer Treat Res Commun; 2021; 26():100297. PubMed ID: 33385734
[TBL] [Abstract][Full Text] [Related]
15. Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.
Li H; Yu L; Zhang X; Shang J; Duan X
Front Immunol; 2022; 13():1036239. PubMed ID: 36389761
[TBL] [Abstract][Full Text] [Related]
16. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer.
Zhou X; Wang N; Zhang Y; Yu H; Wu Q
Invest New Drugs; 2022 Feb; 40(1):43-57. PubMed ID: 34499335
[TBL] [Abstract][Full Text] [Related]
17.
Zhang N; Shen J; Gou L; Cao M; Ding W; Luo P; Zhang J
Bioengineered; 2022 May; 13(5):11577-11592. PubMed ID: 35531878
[TBL] [Abstract][Full Text] [Related]
18. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
[TBL] [Abstract][Full Text] [Related]
19. Exploration of potential shared gene signatures between periodontitis and multiple sclerosis.
Wu E; Cheng M; Zhang X; Wu T; Sheng S; Sheng M; Wei L; Zhang L; Shao W
BMC Oral Health; 2024 Jan; 24(1):75. PubMed ID: 38218802
[TBL] [Abstract][Full Text] [Related]
20. Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma.
Xu T; Dai T; Zeng P; Song Q; He K; Hu Z; Li Y; Li Z
Transl Cancer Res; 2021 Aug; 10(8):3811-3828. PubMed ID: 35116680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
